Recently published data suggest that enteral nutrition ( EN ) , given as systematic artificial nutrition support , could decrease grade III-IV graft-versus-host disease ( GVHD ) and infectious events , which are associated with early toxicity after allo-HSCT and then have an impact on early transplant-related mortality ( D100 mortality ) .